Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of topoisomerase I inhibitor irinotecan (CPT-11) sensitive, resistant, and reverted human neuroblastomas


ABSTRACT: We have established a neuroblastoma model resistant in vivo to the topoisomerase I inhibitor irinotecan (CPT-11, Camptothecin-11, CAMPTOSAR®) in order to study resistance to these agents acquired in a therapeutic setting. Common mechanisms of resistance were not involved in this model and we thus explored the gene expression signature associated with resistance by comparing the transcriptomes of sensitive, resistant, and reverted tumours using high-throughput DNA microarrays.

ORGANISM(S): Homo sapiens

SUBMITTER: Hugues Ripoche 

PROVIDER: E-TABM-211 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2009-03-12 | E-TABM-611 | biostudies-arrayexpress
2006-09-11 | E-TABM-44 | biostudies-arrayexpress
2007-12-27 | E-TABM-359 | biostudies-arrayexpress
2012-11-01 | E-MTAB-1157 | biostudies-arrayexpress
2013-08-13 | E-MTAB-993 | biostudies-arrayexpress
2008-03-31 | E-TABM-327 | biostudies-arrayexpress
2017-11-01 | E-MTAB-4656 | biostudies-arrayexpress
2009-03-26 | E-TABM-309 | biostudies-arrayexpress
2009-04-25 | E-TABM-374 | biostudies-arrayexpress
2009-04-25 | E-TABM-379 | biostudies-arrayexpress